Orchid Pharma Limited (BOM:524372)
India
· Delayed Price · Currency is INR 719.20
-4.25 (-0.59%)
At close: Jun 6, 2025
Orchid Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 996.57 | 921.67 | 463.18 | -19.51 | -1,165 | Upgrade
|
| Depreciation & Amortization | 345.46 | 321.07 | 547.79 | 869.93 | 1,089 | Upgrade
|
| Other Amortization | - | 11.31 | 0.08 | 0.31 | 0.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | 3.2 | 1.88 | -399.85 | -0 | 0.65 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.15 | -5.12 | -19.42 | Upgrade
|
| Loss (Gain) on Equity Investments | -38.99 | 28.98 | 21.54 | 35.23 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 68.41 | -2.65 | 11.88 | 36.67 | 13.28 | Upgrade
|
| Other Operating Activities | -97.17 | 56.05 | 329.54 | 298.27 | 611.43 | Upgrade
|
| Change in Accounts Receivable | -490.66 | 196.47 | -416.54 | -229.19 | -820.25 | Upgrade
|
| Change in Inventory | -621.45 | -354.88 | -560.82 | 25.37 | -334.99 | Upgrade
|
| Change in Accounts Payable | -67.82 | 548.51 | 139.14 | 473.63 | 179.31 | Upgrade
|
| Change in Other Net Operating Assets | 94.61 | -468.48 | 47.59 | 325.86 | 606.33 | Upgrade
|
| Operating Cash Flow | 192.15 | 1,260 | 183.38 | 924.75 | 235.86 | Upgrade
|
| Operating Cash Flow Growth | -84.75% | 587.05% | -80.17% | 292.07% | -70.81% | Upgrade
|
| Capital Expenditures | -1,501 | -648.15 | -849.13 | -144.04 | -6.04 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 585.46 | 0.99 | 2.86 | Upgrade
|
| Divestitures | - | - | - | 1,594 | - | Upgrade
|
| Investment in Securities | 1,044 | -2,592 | -53.07 | -326.55 | 668.52 | Upgrade
|
| Other Investing Activities | 187.39 | 120.02 | 4.61 | 4.88 | 6.71 | Upgrade
|
| Investing Cash Flow | -269.31 | -3,120 | -312.14 | 1,129 | 672.05 | Upgrade
|
| Short-Term Debt Issued | 285.56 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 1,732 | 199.99 | - | Upgrade
|
| Total Debt Issued | 285.56 | - | 1,732 | 199.99 | - | Upgrade
|
| Long-Term Debt Repaid | -2.21 | -2,085 | -1,098 | -2,048 | -1,251 | Upgrade
|
| Total Debt Repaid | -2.21 | -2,085 | -1,098 | -2,048 | -1,251 | Upgrade
|
| Net Debt Issued (Repaid) | 283.35 | -2,085 | 633.92 | -1,848 | -1,251 | Upgrade
|
| Issuance of Common Stock | - | 3,919 | - | - | - | Upgrade
|
| Other Financing Activities | -31.13 | -163.55 | -322.26 | -320.12 | -399.09 | Upgrade
|
| Financing Cash Flow | 252.22 | 1,670 | 311.66 | -2,168 | -1,650 | Upgrade
|
| Net Cash Flow | 175.06 | -189.96 | 182.91 | -113.87 | -741.98 | Upgrade
|
| Free Cash Flow | -1,309 | 611.77 | -665.75 | 780.71 | 229.82 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 239.71% | -69.98% | Upgrade
|
| Free Cash Flow Margin | -14.20% | 7.47% | -10.00% | 13.95% | 5.11% | Upgrade
|
| Free Cash Flow Per Share | -25.81 | 12.65 | -16.31 | 19.13 | 5.63 | Upgrade
|
| Cash Interest Paid | 31.13 | 163.55 | 322.26 | 320.12 | 399.09 | Upgrade
|
| Cash Income Tax Paid | 9.37 | -6.29 | 2.99 | 19.06 | -49.23 | Upgrade
|
| Levered Free Cash Flow | 834.85 | -2,498 | -1,048 | 2,206 | 100.7 | Upgrade
|
| Unlevered Free Cash Flow | 925.72 | -2,396 | -846.73 | 2,406 | 421.55 | Upgrade
|
| Change in Net Working Capital | -1,565 | 2,565 | 726.67 | -1,892 | 345.98 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.